Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
Conference Co-Chairs from Merck & AstraZeneca Invitation to Join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference. - December 16, 2022 - SAE Media Group
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars
Ramsey Asmar, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the addition of board-certified hematologist-oncologist Ramsey Asmar, MD. He will practice at 2236 Nostrand Avenue, Brooklyn, NY 11205. “We are very excited to welcome... - December 01, 2022 - New York Cancer & Blood Specialists
Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company
Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy
Exploring the Implementation of Complex In-Vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK. - November 28, 2022 - SAE Media Group
Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility
The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen
Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial
In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not perform meaningfully better than a placebo. About 25% of all patients who received gantenerumab were also associated with higher rates of an imaging abnormality that can... - November 19, 2022 - Biomed Industries Inc.
Virb Lands Contract with $10B Life Sciences Company
Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb
Nuvem, a Leading Pharmacy Technology & Services Company, Appoints New CEO
Nuvem (or the “Company”), a high-growth, healthcare technology company offering an integrated suite of pharmacy claims administration technology, related analytics and onsite pharmacy management services to safety net healthcare providers, announced that Matthew Umscheid has joined the... - November 10, 2022 - Nuvem
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order
Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical
Pharma/Vaccine Exec Brad Thompson Joins Fuld & Company as Advisory Board Member
Fuld & Company welcomes Pharma/Vaccine Exec Brad Thompson as an Advisory Board Member. Brad brings over twenty years of experience building franchise and brand strategies in the vaccine and pharmaceutical space. He will be an instrumental member of Fuld's HLS team to help propel the success of the company's pharma and biotech clients. - November 03, 2022 - Fuld & Company
CancerLife Announces a New Platform to Address Disparities of Care with Breast Cancer
CancerLife announces the results of a clinical trial where QoL was raised by 14.3% across all care settings, which proves it solution can address disparities of care. - October 29, 2022 - CancerLife
Dr. Pam Gumbs Recognized as a Woman of the Month for September 2022 By P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)
Dr. Pam Gumbs of Berkeley, California has been recognized as a Woman of the Month for September 2022 by P.O.WE.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and achievements in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the... - October 26, 2022 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog
During rehabilitation after being infected with COVID-19, many patients said they experienced "brain fog." According to figures given in the study report, about 10% of patients infected with COVID-19 will experience long COVID. At present, it has become customary in the medical community to classify the symptoms of brain and nerve caused by COVID-19 infection as long-term COVID brain fog. - October 26, 2022 - Long COVID Care Center
Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery
Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule
Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform
Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.
CallonDoc Provides Immediate Healthcare Support Those Affected by Hurricane Ian
CallonDoc is helping those affected by Hurricane Ian by providing immediate access to healthcare. CallonDoc is offering same day online visits and prescriptions for immediate relief and availability to care. - October 08, 2022 - CallonDoc
The IPA Confirms IPAC2022NV Medical Conference at Alexis Park Resort in Las Vegas, NV with CME on Cannabis, Psilocybin, Psychedelics, Mental Health & More
The Integrative Providers Association (IPA) is holding its next Annual Integrative Providers Association Conference 2022 at the Alexis Park Resort in Las Vegas, Nevada, from November 13-15, 2022. Included in the IPACs are a variety of Edutainment and Networking Events, Engaging Pre-Recorded Content on Psychedelics, Cannabis and More with 15 AMA PRA Category 1 Credit(s)TM Centered Around Providers “Transitioning to Individualized Wellness Management” - Plus a Bonus Day-3 Clinical Practicum. - October 06, 2022 - Integrative Providers Association
Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform
The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR
NuvOx Appoints Dr. Katy Peters to SAB
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Katy Peters to its Scientific Advisory Board (SAB). Dr. Katy Peters, MD, Ph.D. FAAN is an associate professor of neurology and... - September 22, 2022 - NuvOx Therapeutics
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Integrated Servo Motors Get More Torque
AMCI is releasing the SV400E2 Integrated Servo Motor, expanding the torque options available within the integrated servo family. By incorporating a servo motor, drive, and controller in a single package they offer a smaller control system which benefits your bottom line and production time. - September 20, 2022 - AMCI
Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022
Event to focus on the connection between CRA experience and performance. - September 20, 2022 - Virb
Record Salesforce Project in the Baltic States: Limedika Picks Salesforce to Streamline Employee Experience
Pharmaceutical company Limedika chooses Salesforce to create an internal employee service center and streamline employee experience across group companies. With nearly 2000 employees, this is one of the largest Salesforce platform deployments in the Baltics. Platform deployment was carried out by specialized full-service Salesforce consultancy Bluelark, which is a part of Agmis technology group. - September 17, 2022 - Agmis
Husson University’s School of Pharmacy Hosted the Rx Abuse Leadership (RALI) Trailer on Campus
Despite recent decreases in teen drug use nationwide, there’s still more to do. In order to help educate and combat overdose and addiction issues locally, Husson partnered with the Rx Abuse Leadership Initiative (RALI) of Maine and Code 3 to increase public awareness of opioid misuse. The University brought a trailer with an educational exhibit set up like a teenager’s bedroom to their Bangor, Maine campus. The trailer is designed to help visitors spot possible warning signs of hidden drugs. - September 14, 2022 - Husson University
Appointments Made to the Sterile Compounding Expert Panel Announced by Pharmacy Stars
The Sterile Compounding Expert Panel (SCXP) was established by Pharmacy Stars on July 7, 2022. Pharmacy Stars executive leadership has appointed key members to serve on SCXP’s panel. They have joined in support of the organization’s mission to strengthen sterile compounding practices in... - September 12, 2022 - Pharmacy Stars, LLC
GENINVO Service Offering Custom Application Development
GENINVO is a leading provider of high-quality, innovative life science tools. GENINVO understand the business challenges of enterprises big and small. Whether you need short-term, focused design support or turnkey product development, GENINVO has the right tools to meet your needs with the help of... - September 07, 2022 - GenInvo, Inc.
Immunize Wisconsin Set to Launch
A new statewide immunization coalition, Immunize Wisconsin, will provide fact-based resources, education, and grants. - September 06, 2022 - Wisconsin Chapter of the American Academy of Pediatrics
BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity
BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs. - September 02, 2022 - BOC Sciences
10 Great Reasons to Join the Next Generation Pharmaceutical Cleanrooms Conference
SAE Media Group reports: Next Generation Pharmaceutical Cleanrooms Conference 2022 will provide delegates the opportunity to delve into the significant changes that the cleanroom industry is going through. - August 30, 2022 - SAE Media Group
PSL Family wCaregivers to Get Answers; Fearless Caregiver Workshop Sept. 22
Limited complimentary tickets are available for the Fearless Caregiver training. The 25th anniversary Fearless Caregiver Conference tour will come to the Port Saint Lucie Community Center Sept. 22. - August 26, 2022 - Caregiver.com, Inc.
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical
Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years
Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the industry-leading experience that has made Pharma CI the gold standard event for more than fifteen years. The much-anticipated return happens this September 21-22 at the Newark Liberty... - August 18, 2022 - Pharma CI Conference
Hospice Home Care Expands to Cover All of Los Angeles County
Every city in Los Angeles Country will be serviced by Hospice Home Care. The department that has been created will allow doctors, nurses, volunteers and other hospice care professionals to service thousands of patients in the Los Angeles area. - August 08, 2022 - Hospice Home Care
House Rx and QCCA Partner to Improve Medically Integrated Drug Dispensing at Community Oncology Clinics
House Rx, the platform for medically integrated dispensing of specialty medications, today announced a partnership with the Quality Cancer Care Alliance (QCCA) to provide QCCA-affiliated practices with an analytical snapshot of their in-office specialty drug dispensing operations, known as... - August 08, 2022 - House Rx
Jedsy to Participate at 2022 AACC
Drone delivery made for Laboratories. - July 25, 2022 - Jedsy
Heartland Pharmacy Creates New Collaborative Care Program
Heartland Pharmacy is launching a new senior care program to promote collaborative care for advanced physical wellness. - July 21, 2022 - Heartland Pharmacy
International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals
A new peer-reviewed report by a panel of scientists sheds new light on regulation and management of per- and polyfluoroalkyl substances (PFAS). SciPinion, which objectively engages the global scientific community to analyze the toughest scientific topics, today announced the publication of an... - July 19, 2022 - SciPinion
House Rx Partners with Two Leading Oncology Clinics to Enhance Medically Integrated Dispensing of Cancer Therapies
House Rx, the platform for medically integrated dispensing of specialty medications for cancer care, rheumatoid arthritis and other complex medical conditions, announced, today, it has partnered with two leading oncology clinics — Cancer Care Associates of York and Pacific Cancer Care —... - July 18, 2022 - House Rx
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network
Pharmacy Stars to launch the Sterile Compounding Quality Peer Network with the goal of filling the vacated role of CriticalPoint’s Peer Network, an online forum designed to support 503A entities, their regulators, and their certifiers. The CriticalPoint Peer Network has been discontinued as of June 30, 2022, according to the CriticalPoint website. - July 11, 2022 - Pharmacy Stars, LLC
Dr. Pam Gumbs Celebrated as an Honored Member by P.O.W.E.R. - Professional Organization of Women of Excellence Recognized
Dr. Pam Gumbs of Berkeley, California, has been named as an honored member of P.O.WE.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About Dr. Pam Gumbs Affectionately known as... - June 29, 2022 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Process Insights Announces the Acquisition of the Assets of the Process Analyzers Business from Schneider Electric
Process Insights, a Union Park Capital portfolio company, announced today the acquisition of the assets of the Process Analyzers business from Schneider Electric (“Schneider”). Based in Upland, California, Schneider’s process analyzers deliver premium solutions to leading... - June 26, 2022 - Process Insight
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
GENINVO Launches Its Latest Offering - Innovation as a Service
GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.